Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review-Reference-Cited by-同舟云学术

Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review

Published:2017-07-14 Issue:21 Volume:123 Page:4158-4167
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

de Geus Susanna W. L.¹^ORCID,Eskander Mariam F.¹,Kasumova Gyulnara G.¹,Ng Sing Chau¹,Kent Tara S.¹,Mancias Joseph D.²,Callery Mark P.¹,Mahadevan Anand³,Tseng Jennifer F.¹

Affiliation:

1. Surgical Outcomes Analysis and Research, Beth Israel Deaconess Medical Center; Harvard Medical School; Boston Massachusetts

2. Department of Radiation Oncology; Dana-Farber Cancer Institute/Brigham and Women's Hospital; Boston Massachusetts

3. Department of Radiation Oncology, Beth Israel Deaconess Medical Center; Harvard Medical School; Boston Massachusetts

Funder

American Cancer Society

American Surgical Association Foundation Fellowship

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference36 articles.

1. National Cancer Institute Cancer stat facts: pancreas cancer https://seer.cancer.gov/statfacts/html/pancreas.html 2016

2. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States;Rahib;Cancer Res.,2014

3. Surgery for localized pancreatic cancer: the trend is not improving;Strohl;Pancreas.,2016

4. Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines;Tempero;J Natl Compr Canc Netw.,2014

5. Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study;Chauffert;Ann Oncol.,2008

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer after FOLFIRINOX chemotherapy;Clinical and Translational Radiation Oncology;2024-03

2. Multifunctional exosome-driven pancreatic cancer diagnostics and therapeutics;Extracellular Vesicle;2023-12

3. Pancreatic Ductal Adenocarcinoma: Update of CT-Based Radiomics Applications in the Pre-Surgical Prediction of the Risk of Post-Operative Fistula, Resectability Status and Prognosis;Journal of Clinical Medicine;2023-11-28

4. Involved-Field Radiation Therapy for Patients With Unresectable Pancreatic Adenocarcinomas: Failure Pattern Analysis;Cureus;2023-11-01

5. Assessment of interfraction dose variation in pancreas SBRT using daily simulation MR images;Physical and Engineering Sciences in Medicine;2023-09-25